PCOS Is Being Renamed PMOS

A New Name for a Common Condition

For years, healthcare providers have known that the name Polycystic Ovary Syndrome (PCOS) doesn't accurately describe the condition.

Despite being one of the most common hormonal disorders affecting women, many patients with PCOS don't actually have ovarian cysts. Others are told they can't have PCOS because an ultrasound didn't show cysts, despite having symptoms that clearly fit the diagnosis.

As our understanding of this condition has evolved, experts around the world have recognized that the name itself may be contributing to confusion, delayed diagnosis, and misunderstandings about what PCOS really is.

That's why an international group of researchers, physicians, and patient advocates recently recommended changing the name from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS).

While it may take years for the new terminology to become commonplace, many healthcare professionals are excited about this change because it better reflects what we now know about the condition.

Why Was the Name PCOS a Problem?

The term "polycystic ovary syndrome" was first introduced decades ago when doctors believed ovarian cysts were the defining feature of the condition.

We now know that's not true.

In fact:

• Many women with PCOS do not have ovarian cysts.

• The "cysts" seen on ultrasound are actually immature follicles, not true cysts.

• The condition affects much more than the ovaries.

• Metabolic health is often a major component of the disorder.

The name focuses on a single feature that may or may not be present while ignoring many of the symptoms that patients experience every day.

Women with PCOS often struggle with:

• Irregular or absent periods

• Infertility or difficulty ovulating

• Weight gain

• Insulin resistance

• Acne

• Excess facial or body hair

• Hair loss

• Fatigue

• Mood concerns

• Increased risk of diabetes

• Increased risk of cardiovascular disease

When you look at that list, it's easy to see why experts felt the old name was no longer sufficient.

What Does PMOS Stand For?

PMOS stands for: Polyendocrine Metabolic Ovarian Syndrome

Polyendocrine:

"Poly" means many, and "endocrine" refers to hormones.

This highlights the fact that multiple hormone systems are involved, not just the ovaries.

Women with PMOS may have abnormalities involving:

• Insulin

• Testosterone and other androgens

• Estrogen

• Progesterone

• LH and FSH

• Cortisol

• Appetite-regulating hormones

This is a whole-body hormonal condition, not simply an ovarian disorder.

Metabolic:

This is perhaps the most important addition to the name.

Research has consistently shown that metabolic dysfunction plays a central role in many cases of PCOS.

Many women have:

• Insulin resistance

• Elevated insulin levels

• Difficulty losing weight

• Increased risk of prediabetes

• Increased risk of Type 2 diabetes

• Increased cardiovascular risk

By including "metabolic" in the name, experts hope to draw attention to one of the most important drivers of the condition.

Ovarian:

The ovaries remain an important part of the syndrome because ovulation and reproductive function are commonly affected.

However, the ovaries are no longer viewed as the entire story.

Syndrome

The term syndrome indicates that this is a collection of symptoms and clinical findings rather than a single disease process.

Why the Medical Community Is Excited

At first glance, changing a name may not seem like a big deal.

However, names influence how conditions are understood, diagnosed, researched, and treated.

1. It Better Reflects Current Science

Our understanding of PCOS has changed dramatically over the past several decades.

We now know that:

• Insulin resistance is common

• Chronic inflammation may play a role

• Genetic factors contribute

• Metabolic dysfunction often develops before reproductive symptoms

• The condition affects multiple organ systems

The new name aligns more closely with what researchers have discovered.

2. It Helps Patients Feel Seen

Many women have expressed frustration after being told they have a condition called "polycystic ovary syndrome" despite never having ovarian cysts.

Others spend years wondering why they're experiencing fatigue, weight gain, blood sugar issues, or inflammation when all the focus seems to be on their ovaries.

PMOS acknowledges that this condition affects the entire body.

3. It Encourages Earlier Screening

When clinicians think of PMOS as a metabolic condition rather than strictly a reproductive disorder, it may encourage earlier screening for:

• Insulin resistance

• Prediabetes

• Type 2 diabetes

• Cardiovascular risk factors

• Fatty liver disease

Early intervention can significantly improve long-term outcomes.

4. It May Improve Treatment Approaches

Historically, treatment often focused on managing symptoms.

For example:

• Birth control pills for irregular cycles

• Fertility medications for ovulation

• Anti-androgen medications for acne and hair growth

While these treatments can be helpful, the new terminology may encourage healthcare providers to also address underlying metabolic dysfunction through:

• Nutrition

• Exercise

• Sleep optimization

• Stress management

• Insulin-sensitizing medications

• Targeted supplementation when appropriate

What Hasn't Changed?

While the name is changing, the diagnostic criteria remain largely the same.

Most women are still diagnosed based on a combination of:

• Irregular ovulation or menstrual cycles

• Elevated androgen levels or symptoms of androgen excess

• Polycystic ovarian morphology on ultrasound

The condition itself has not changed.

What has changed is our understanding of it.

What This Means for Patients

If you currently have a diagnosis of PCOS, there is no need to worry.

Your diagnosis is still valid.

The new name does not mean you have a different condition. Rather, it reflects a broader and more accurate understanding of what has likely been happening in your body all along.

The shift toward PMOS may help healthcare providers focus more on:

• Metabolic health

• Blood sugar regulation

• Inflammation

• Long-term cardiovascular health

• Whole-body hormone balance

These are areas that many practitioners have already been addressing, but the new terminology helps bring them to the forefront.

The Future of PMOS

Medical terminology evolves as science evolves.

The transition from PCOS to PMOS will likely take time. Patients will continue to hear both terms used for years, and many medical organizations are still working through implementation.

However, the growing support for the new name reflects a broader shift in medicine toward understanding this condition as much more than an ovarian disorder.

For many women, that's an important step forward.

By recognizing the hormonal, metabolic, inflammatory, and reproductive aspects of the condition, we move closer to more comprehensive care and better long-term outcomes.

The name may be changing, but the goal remains the same: helping women understand their bodies, improve their health, and receive the care they deserve.

Looking for Support With PCOS or PMOS?

Whether you've recently been diagnosed or have been managing symptoms for years, a comprehensive approach can help address both the hormonal and metabolic aspects of the condition.

At our clinic, we assess factors such as insulin resistance, menstrual cycle patterns, ovulation, nutrition, stress, sleep, and hormone balance to create an individualized treatment plan designed to support both short-term symptom relief and long-term health.